Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
IRC002 Study Team
Medicine
Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
90
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Adult Respiratory Distress Syndrome
13%
Air
9%
Antibodies
13%
Artificial Respiration
11%
Child
5%
Hemagglutination
13%
Hospitalized Child
14%
Human Influenza
100%
Hypoxia
9%
Morbidity
7%
Mortality
6%
National Institute of Allergy and Infectious Diseases (U.S.)
18%
National Institutes of Health (U.S.)
12%
Oxygen
8%
Pediatrics
7%
Polymerase Chain Reaction
7%
Pregnant Women
9%
Respiratory Rate
12%
Safety
7%
Standard of Care
23%
Stroke
8%
Tachypnea
15%
Therapeutics
17%